Fulton Breakefield Broenniman LLC Sells 5,708 Shares of UnitedHealth Group Incorporated $UNH

Fulton Breakefield Broenniman LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 49,127 shares of the healthcare conglomerate’s stock after selling 5,708 shares during the period. UnitedHealth Group comprises approximately 1.1% of Fulton Breakefield Broenniman LLC’s portfolio, making the stock its 25th largest position. Fulton Breakefield Broenniman LLC’s holdings in UnitedHealth Group were worth $16,963,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Murphy Pohlad Asset Management LLC increased its holdings in UnitedHealth Group by 21.8% in the 2nd quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock worth $1,380,000 after acquiring an additional 791 shares during the last quarter. Berkshire Hathaway Inc purchased a new position in shares of UnitedHealth Group in the second quarter worth about $1,572,193,000. Triumph Capital Management purchased a new stake in shares of UnitedHealth Group during the 2nd quarter valued at approximately $1,324,000. Wealth Effects LLC raised its holdings in UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after acquiring an additional 591 shares during the period. Finally, IFP Advisors Inc boosted its holdings in shares of UnitedHealth Group by 20.7% in the second quarter. IFP Advisors Inc now owns 20,683 shares of the healthcare conglomerate’s stock worth $6,462,000 after acquiring an additional 3,545 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Morgan Stanley raised their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. The Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They set a “buy” rating and a $406.00 target price on the stock. Royal Bank Of Canada raised their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. UBS Group lifted their price objective on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Finally, KeyCorp upped their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Seventeen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Hold” and an average price target of $385.54.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $331.76 on Friday. The firm has a fifty day simple moving average of $333.71 and a two-hundred day simple moving average of $318.99. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The company has a market capitalization of $300.52 billion, a PE ratio of 17.32, a P/E/G ratio of 2.13 and a beta of 0.43. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the prior year, the business posted $7.15 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s payout ratio is currently 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.